Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2021 | IpiNovyx Bio | $10.0M Seed | — | Ad Astra Ventures, Leawood Venture Capital, Alexandria Venture Investments, Eli Lilly and Company, Marc Spencer Appel |
| Apr 1, 2021 | Tesseract Health | $80.0M Series B | — | ARCH Venture Partners, Foresite Capital, Krishna Yeshwant, VZVC, Larry Robbins |
| May 1, 2020 | Palvella Therapeutics | $45.0M Series C | — | Samsara BioCapital, Adams Street Partners, Agent Capital, BioAdvance, BVF Partners, Scott Morenstein, Ligand Pharmaceuticals, Sean Nolan |
| Jun 20, 2019 | Acutus Medical | $170.0M Debt / Series D | — | Vince Burgess, Advent Venture Partners, Deerfield Management, GE Ventures, OrbiMed, Pura Vida Investments, Xeraya Capital |